Mechanistic insights into the more potent effect of KP-54 compared to KP-10 in vivo.

Kisspeptins regulate the mammalian reproductive axis by stimulating release of gonadotrophin releasing hormone (GnRH). Different length kisspeptins (KP) are found of 54, 14, 13 or 10 amino-acids which share a common C-terminal 10-amino acid sequence. KP-54 and KP-10 have been widely used to stimulat...

Full description

Saved in:
Bibliographic Details
Main Authors: Xavier d'Anglemont de Tassigny, Channa N Jayasena, Kevin G Murphy, Waljit S Dhillo, William H Colledge
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0176821&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850232486059048960
author Xavier d'Anglemont de Tassigny
Channa N Jayasena
Kevin G Murphy
Waljit S Dhillo
William H Colledge
author_facet Xavier d'Anglemont de Tassigny
Channa N Jayasena
Kevin G Murphy
Waljit S Dhillo
William H Colledge
author_sort Xavier d'Anglemont de Tassigny
collection DOAJ
description Kisspeptins regulate the mammalian reproductive axis by stimulating release of gonadotrophin releasing hormone (GnRH). Different length kisspeptins (KP) are found of 54, 14, 13 or 10 amino-acids which share a common C-terminal 10-amino acid sequence. KP-54 and KP-10 have been widely used to stimulate the reproductive axis but data suggest that KP-54 and KP-10 are not equally effective at eliciting reproductive hormone secretion after peripheral delivery. To confirm this, we analysed the effect of systemic administration of KP-54 or KP-10 on luteinizing hormone (LH) secretion into the bloodstream of male mice. Plasma LH measurements 10 min or 2 hours after kisspeptin injection showed that KP-54 can sustain LH release far longer than KP-10, suggesting a differential mode of action of the two peptides. To investigate the mechanism for this, we evaluated the pharmacokinetics of the two peptides in vivo and their potential to cross the blood brain barrier (BBB). We found that KP-54 has a half-life of ~32 min in the bloodstream, while KP-10 has a half-life of ~4 min. To compensate for this difference in half-life, we repeated injections of KP-10 every 10 min over 1 hr but failed to reproduce the sustained rise in LH observed after a single KP-54 injection, suggesting that the failure of KP-10 to sustain LH release may not just be related to peptide clearance. We tested the ability of peripherally administered KP-54 and KP-10 to activate c-FOS in GnRH neurons behind the blood brain barrier (BBB) and found that only KP-54 could do this. These data are consistent with KP-54 being able to cross the BBB and suggest that KP10 may be less able to do so.
format Article
id doaj-art-69492816e5de4dcd92c0412ad4c3b4cd
institution OA Journals
issn 1932-6203
language English
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-69492816e5de4dcd92c0412ad4c3b4cd2025-08-20T02:03:12ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01125e017682110.1371/journal.pone.0176821Mechanistic insights into the more potent effect of KP-54 compared to KP-10 in vivo.Xavier d'Anglemont de TassignyChanna N JayasenaKevin G MurphyWaljit S DhilloWilliam H ColledgeKisspeptins regulate the mammalian reproductive axis by stimulating release of gonadotrophin releasing hormone (GnRH). Different length kisspeptins (KP) are found of 54, 14, 13 or 10 amino-acids which share a common C-terminal 10-amino acid sequence. KP-54 and KP-10 have been widely used to stimulate the reproductive axis but data suggest that KP-54 and KP-10 are not equally effective at eliciting reproductive hormone secretion after peripheral delivery. To confirm this, we analysed the effect of systemic administration of KP-54 or KP-10 on luteinizing hormone (LH) secretion into the bloodstream of male mice. Plasma LH measurements 10 min or 2 hours after kisspeptin injection showed that KP-54 can sustain LH release far longer than KP-10, suggesting a differential mode of action of the two peptides. To investigate the mechanism for this, we evaluated the pharmacokinetics of the two peptides in vivo and their potential to cross the blood brain barrier (BBB). We found that KP-54 has a half-life of ~32 min in the bloodstream, while KP-10 has a half-life of ~4 min. To compensate for this difference in half-life, we repeated injections of KP-10 every 10 min over 1 hr but failed to reproduce the sustained rise in LH observed after a single KP-54 injection, suggesting that the failure of KP-10 to sustain LH release may not just be related to peptide clearance. We tested the ability of peripherally administered KP-54 and KP-10 to activate c-FOS in GnRH neurons behind the blood brain barrier (BBB) and found that only KP-54 could do this. These data are consistent with KP-54 being able to cross the BBB and suggest that KP10 may be less able to do so.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0176821&type=printable
spellingShingle Xavier d'Anglemont de Tassigny
Channa N Jayasena
Kevin G Murphy
Waljit S Dhillo
William H Colledge
Mechanistic insights into the more potent effect of KP-54 compared to KP-10 in vivo.
PLoS ONE
title Mechanistic insights into the more potent effect of KP-54 compared to KP-10 in vivo.
title_full Mechanistic insights into the more potent effect of KP-54 compared to KP-10 in vivo.
title_fullStr Mechanistic insights into the more potent effect of KP-54 compared to KP-10 in vivo.
title_full_unstemmed Mechanistic insights into the more potent effect of KP-54 compared to KP-10 in vivo.
title_short Mechanistic insights into the more potent effect of KP-54 compared to KP-10 in vivo.
title_sort mechanistic insights into the more potent effect of kp 54 compared to kp 10 in vivo
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0176821&type=printable
work_keys_str_mv AT xavierdanglemontdetassigny mechanisticinsightsintothemorepotenteffectofkp54comparedtokp10invivo
AT channanjayasena mechanisticinsightsintothemorepotenteffectofkp54comparedtokp10invivo
AT kevingmurphy mechanisticinsightsintothemorepotenteffectofkp54comparedtokp10invivo
AT waljitsdhillo mechanisticinsightsintothemorepotenteffectofkp54comparedtokp10invivo
AT williamhcolledge mechanisticinsightsintothemorepotenteffectofkp54comparedtokp10invivo